Solomon Epstein

5.4k total citations · 1 hit paper
72 papers, 3.7k citations indexed

About

Solomon Epstein is a scholar working on Orthopedics and Sports Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Solomon Epstein has authored 72 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Orthopedics and Sports Medicine, 35 papers in Molecular Biology and 31 papers in Oncology. Recurrent topics in Solomon Epstein's work include Bone health and treatments (29 papers), Bone Metabolism and Diseases (23 papers) and Bone and Joint Diseases (21 papers). Solomon Epstein is often cited by papers focused on Bone health and treatments (29 papers), Bone Metabolism and Diseases (23 papers) and Bone and Joint Diseases (21 papers). Solomon Epstein collaborates with scholars based in United States, United Kingdom and Canada. Solomon Epstein's co-authors include Yu‐Xiao Yang, James D. Lewis, David C. Metz, C. Conrad Johnston, Mone Zaidi, Angela M. Inzerillo, Richard Aguilar, Barbara E. Corkey, Struan F.A. Grant and Stanley S. Schwartz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Clinical Investigation.

In The Last Decade

Solomon Epstein

71 papers receiving 3.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture

2006 914 citations Yu‐Xiao Yang, James D. Lewis et al. JAMA profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Solomon Epstein	1.1k	1.1k	1.1k	986	592	72	3.7k
E. Alhava	1.2k 1.0×	1.4k 1.2×	1.3k 1.2×	1.6k 1.6×	282 0.5×	156	5.3k
Matti Välimäki	907 0.8×	1.3k 1.1×	1.3k 1.2×	1.1k 1.2×	213 0.4×	159	6.3k
E.B. Mawer	746 0.6×	1.1k 0.9×	803 0.7×	512 0.5×	122 0.2×	131	5.3k
Ranuccio Nuti	1.4k 1.2×	2.4k 2.1×	1.6k 1.5×	1.0k 1.0×	74 0.1×	253	6.4k
H. Schmidt‐Gayk	510 0.4×	635 0.6×	772 0.7×	329 0.3×	33 0.1×	110	2.8k
C. E. Dent	1.2k 1.0×	464 0.4×	819 0.7×	467 0.5×	55 0.1×	107	5.2k
Pascal Houillier	2.2k 1.9×	411 0.4×	426 0.4×	728 0.7×	37 0.1×	169	6.6k
Thomas O. Carpenter	1.2k 1.0×	1.0k 0.9×	1.4k 1.3×	651 0.7×	27 0.0×	158	7.3k
Antongiulio Faggiano	938 0.8×	219 0.2×	2.9k 2.6×	2.2k 2.3×	118 0.2×	285	8.9k
René Rizzoli	1.1k 1.0×	2.4k 2.1×	1.0k 0.9×	1.1k 1.1×	19 0.0×	78	4.7k

Countries citing papers authored by Solomon Epstein

Since Specialization

Citations

This map shows the geographic impact of Solomon Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Solomon Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Solomon Epstein more than expected).

Fields of papers citing papers by Solomon Epstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Solomon Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Solomon Epstein. The network helps show where Solomon Epstein may publish in the future.

Co-authorship network of co-authors of Solomon Epstein

This figure shows the co-authorship network connecting the top 25 collaborators of Solomon Epstein. A scholar is included among the top collaborators of Solomon Epstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Solomon Epstein. Solomon Epstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Conte, Caterina, Solomon Epstein, & Nicola Napoli. (2018). Insulin resistance and bone: a biological partnership. Acta Diabetologica. 55(4). 305–314. 94 indexed citations

Bone, Henry G., et al.. (2017). Pharmacokinetics of coadministration of levothyroxine sodium and alendronate sodium new effervescent formulation. Osteoporosis International. 28(5). 1745–1752. 5 indexed citations

Schwartz, Stanley S., Solomon Epstein, Barbara E. Corkey, et al.. (2017). A Unified Pathophysiological Construct of Diabetes and its Complications. Trends in Endocrinology and Metabolism. 28(9). 645–655. 81 indexed citations

Zaidi, Mone, Charles H. Turner, Ernesto Canalis, et al.. (2009). Bone loss or lost bone: Rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss. Current Osteoporosis Reports. 7(4). 118–126. 39 indexed citations

Emkey, Ronald, Pierre D. Delmas, Michael A. Bolognese, et al.. (2009). Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): Additional results from the monthly oral therapy with ibandronate for osteoporosis intervention (MOTION) study. Clinical Therapeutics. 31(4). 751–761. 26 indexed citations

Pazianas, Michael, Solomon Epstein, & Mone Zaidi. (2009). Evaluating the Antifracture Efficacy of Bisphosphonates. Reviews on Recent Clinical Trials. 4(2). 122–130. 16 indexed citations

Zaidi, Mone, Solomon Epstein, Steven T. Harris, Joseph D. Kohles, & Charles H. Chesnut. (2007). Progression of Efficacy with Ibandronate. Annals of the New York Academy of Sciences. 1117(1). 273–282. 11 indexed citations

Epstein, Solomon. (2007). Is treatment of early postmenopausal women with bisphosphonates justified?. International Journal of Clinical Practice. 61(6). 963–971. 3 indexed citations

Epstein, Solomon. (2006). Update of current therapeutic options for the treatment of postmenopausal osteoporosis. Clinical Therapeutics. 28(2). 151–173. 75 indexed citations

10.

Yang, Yu‐Xiao, James D. Lewis, Solomon Epstein, & David C. Metz. (2006). Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture. JAMA. 296(24). 2947–2947. 914 indexed citations breakdown →

11.

Epstein, Solomon & Mone Zaidi. (2005). Biological properties and mechanism of action of ibandronate: Application to the treatment of osteoporosis. Bone. 37(4). 433–440. 20 indexed citations

12.

Epstein, Solomon. (2005). The Roles of Bone Mineral Density, Bone Turnover, and Other Properties in Reducing Fracture Risk During Antiresorptive Therapy. Mayo Clinic Proceedings. 80(3). 379–388. 49 indexed citations

13.

Barrett, Joanne, E. Worth, Frieder Bauss, & Solomon Epstein. (2004). Ibandronate: A Clinical Pharmacological and Pharmacokinetic Update. The Journal of Clinical Pharmacology. 44(9). 951–965. 123 indexed citations

14.

Awumey, Emmanuel M., Baljit S. Moonga, Bali R. Sodam, et al.. (1999). Molecular and Functional Evidence for Calcineurin-A α and β Isoforms in the Osteoclast: Novel Insights into Cyclosporin A Action on Bone Resorption. Biochemical and Biophysical Research Communications. 254(1). 248–252. 38 indexed citations

15.

Mann, Gary N., David A. Sass, Farrel J. Buchinsky, et al.. (1996). Short-term systemic insulin-like growth factor-1 is unable to prevent cyclosporin A-induced osteopenia in the rat. Calcified Tissue International. 59(1). 38–44. 7 indexed citations

16.

Shane, E & Solomon Epstein. (1994). Immunosuppressive therapy and the skeleton. Trends in Endocrinology and Metabolism. 5(4). 169–175. 16 indexed citations

17.

Mann, Gary N., Thomas Jacobs, Farrel J. Buchinsky, et al.. (1994). Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia.. Endocrinology. 135(3). 1077–1083. 56 indexed citations

18.

Joffe, Ian I. & Solomon Epstein. (1991). Osteoporosis associated with rheumatoid arthritis: Pathogenesis and management. Seminars in Arthritis and Rheumatism. 20(4). 256–272. 79 indexed citations

19.

Movsowitz, Colin, et al.. (1990). Combined treatment with cyclosporin A and cortisone acetate minimizes the adverse bone effects of either agent alone. Journal of Orthopaedic Research®. 8(5). 635–641. 42 indexed citations

20.

Turner, Russell T., Jonathan Farley, Jacob J. Vandersteenhoven, et al.. (1988). Demonstration of reduced mitogenic and osteoinductive activities in demineralized allogeneic bone matrix from vitamin D-deficient rats.. Journal of Clinical Investigation. 82(1). 212–217. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact